| ESO, CNIO and NRCO Conference on Familial Cancer Presented by: European School of Oncology | Centro Nacional de Investigaciones Oncológicas | Nature Reviews Clinical Oncology May 19-20, 2016 Ateneo de Madrid | Madrid, Spain #FamilialCancer16 | | | | This conference brings together leading researchers and clinicians involved in the diagnosis, treatment and follow-up of patients with familial cancer. The biannual event aims to present advances in the field from a multidisciplinary point of view. | | | | | SCIENTIFIC SESSIONS WILL COVER TOPICS INCLUDING: - Breast and ovarian cancer
- Colon and prostate cancer
- Rare cancers
- Implications of applying next generation sequencing to the diagnosis
| | | | LEARNING OBJECTIVES - Selection criteria, landscape of breast and ovarian cancer genes, and clinical management
- Genetics and clinical management of hereditary colorectal cancer
- Therapeutic strategies in the era of personalized medicine
- Translating genetic risk factors to the surveillance and clinical management of prostate cancer
- Rare cancers: Gastric cancer, pancreatic cancer, tuberous sclerosis, Gorlin syndrome, PTEn and related diseases, multiple endocrine neoplasia type 1, among others
- Implications of applying next generation sequencing to the diagnosis
| | | | ORGANIZERS - Rosalind Eeles (NHS Trust and the Institute for Cancer Research, Sutton, UK))
- William Foulkes (Lady Davis Institute for Medical Research, Montreal, CA)
- Mercedes Robledo (Centro Nacional de Investigaciones Oncólogicas (CNIO), Madrid, ES)
- Hans Vasen (Leiden University Medical Centre, NT)
- Lisa Hutchinson (Nature Reviews Clinical Oncology, UK)
| | | |
No comments:
Post a Comment